Alan G. Levin - 28 Feb 2023 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
28 Feb 2023
Net transactions value
+$11,248
Form type
4
Filing time
02 Mar 2023, 15:37:46 UTC
Previous filing
02 Dec 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $11,248 +1,271 +7.2% $8.85 18,985 28 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $11,250.